These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20801430)

  • 1. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.
    Mascia P; Pistis M; Justinova Z; Panlilio LV; Luchicchi A; Lecca S; Scherma M; Fratta W; Fadda P; Barnes C; Redhi GH; Yasar S; Le Foll B; Tanda G; Piomelli D; Goldberg SR
    Biol Psychiatry; 2011 Apr; 69(7):633-41. PubMed ID: 20801430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.
    Justinova Z; Panlilio LV; Moreno-Sanz G; Redhi GH; Auber A; Secci ME; Mascia P; Bandiera T; Armirotti A; Bertorelli R; Chefer SI; Barnes C; Yasar S; Piomelli D; Goldberg SR
    Neuropsychopharmacology; 2015 Aug; 40(9):2185-97. PubMed ID: 25754762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.
    Luchicchi A; Lecca S; Carta S; Pillolla G; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    Addict Biol; 2010 Jul; 15(3):277-88. PubMed ID: 20477753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
    Scherma M; Justinová Z; Zanettini C; Panlilio LV; Mascia P; Fadda P; Fratta W; Makriyannis A; Vadivel SK; Gamaleddin I; Le Foll B; Goldberg SR
    Br J Pharmacol; 2012 Apr; 165(8):2539-48. PubMed ID: 21557729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
    Panlilio LV; Justinova Z; Mascia P; Pistis M; Luchicchi A; Lecca S; Barnes C; Redhi GH; Adair J; Heishman SJ; Yasar S; Aliczki M; Haller J; Goldberg SR
    Neuropsychopharmacology; 2012 Jul; 37(8):1838-47. PubMed ID: 22453137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
    D'Souza MS; Markou A
    Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
    Qu C; Leung SW; Vanhoutte PM; Man RY
    Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
    Forget B; Wertheim C; Mascia P; Pushparaj A; Goldberg SR; Le Foll B
    Neuropsychopharmacology; 2010 Jul; 35(8):1751-60. PubMed ID: 20357760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
    Fu Y; Matta SG; Gao W; Sharp BM
    Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
    Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
    Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
    Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.
    Mazzola C; Medalie J; Scherma M; Panlilio LV; Solinas M; Tanda G; Drago F; Cadet JL; Goldberg SR; Yasar S
    Learn Mem; 2009 May; 16(5):332-7. PubMed ID: 19403796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.
    Liechti ME; Lhuillier L; Kaupmann K; Markou A
    J Neurosci; 2007 Aug; 27(34):9077-85. PubMed ID: 17715344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.
    Higgins GA; Silenieks LB; Rossmann A; Rizos Z; Noble K; Soko AD; Fletcher PJ
    Neuropsychopharmacology; 2012 Apr; 37(5):1177-91. PubMed ID: 22189292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.
    Melis M; Scheggi S; Carta G; Madeddu C; Lecca S; Luchicchi A; Cadeddu F; Frau R; Fattore L; Fadda P; Ennas MG; Castelli MP; Fratta W; Schilstrom B; Banni S; De Montis MG; Pistis M
    J Neurosci; 2013 Apr; 33(14):6203-11. PubMed ID: 23554501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.
    Justinova Z; Panlilio LV; Secci ME; Redhi GH; Schindler CW; Cross AJ; Mrzljak L; Medd A; Shaham Y; Goldberg SR
    Biol Psychiatry; 2015 Oct; 78(7):452-62. PubMed ID: 25802079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.
    Petrie GN; Wills KL; Piscitelli F; Smoum R; Limebeer CL; Rock EM; Humphrey AE; Sheppard-Perkins M; Lichtman AH; Mechoulam R; Di Marzo V; Parker LA
    Psychopharmacology (Berl); 2019 Sep; 236(9):2623-2633. PubMed ID: 30993360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.